Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Replimune Group, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 140 | 150 | +10 |
| Shares | 66.0M | 67.0M | +1.01M (+1.5%) |
| Value | $556.8M | $547.8M | −$9.05M (−1.6%) |
New holders (29)
Institutions that held Replimune Group, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (19)
Institutions that held Replimune Group, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Artal Group S.A. | 500,000 | $4.21M |
| Canada Pension Plan Investment Board | 319,000 | $2.69M |
| Sectoral Asset Management Inc | 305,412 | $2.57M |
| Vontobel Holding Ltd. | 305,412 | $2.57M |
| Ensign Peak Advisors, Inc | 270,007 | $2.28M |
| Group One Trading, L.P. | 135,243 | $1.14M |
| Landscape Capital Management, L.L.C. | 76,869 | $648.0K |
| Anson Funds Management LP | 73,228 | $617.3K |
| AQR Capital Management LLC | 17,825 | $150.3K |
| Squarepoint Ops LLC | 17,716 | $149.3K |
| Sphera Funds Management Ltd. | 16,096 | $135.7K |
| Captrust Financial Advisors | 13,204 | $111.3K |
| 683 Capital Management, LLC | 11,027 | $93.0K |
| Bridgefront Capital, LLC | 10,023 | $84.5K |
| Walleye Trading LLC | 4,163 | $35.1K |
| EverSource Wealth Advisors, LLC | 240 | $2.02K |
| Parallel Advisors, LLC | 150 | $1.26K |
| Bokf, NA | 15 | $126 |
| LMR Partners LLP | 1 | $8 |